JA, H., J, F., T, M., & SL, H. (2024). Duration of therapy of cost-subsidised phentermine and topiramate in patients with obesity: A retrospective medical records audit of an Australian single site. Obesity research & clinical practice, 18(1), 73. https://doi.org/10.1016/j.orcp.2024.01.005
Chicago Style (17th ed.) CitationJA, Houssarini, Franklin J, Markovic T, and Hocking SL. "Duration of Therapy of Cost-subsidised Phentermine and Topiramate in Patients with Obesity: A Retrospective Medical Records Audit of an Australian Single Site." Obesity Research & Clinical Practice 18, no. 1 (2024): 73. https://doi.org/10.1016/j.orcp.2024.01.005.
MLA (9th ed.) CitationJA, Houssarini, et al. "Duration of Therapy of Cost-subsidised Phentermine and Topiramate in Patients with Obesity: A Retrospective Medical Records Audit of an Australian Single Site." Obesity Research & Clinical Practice, vol. 18, no. 1, 2024, p. 73, https://doi.org/10.1016/j.orcp.2024.01.005.